Insider trading

Period: 120 months Stock: STOK Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

66 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

66 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

66 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

66 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
66 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
66 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

66 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
6 Feb 2023
Ticho Barry Chief Medical Officer
Sold, plan not stated
$92.49K 9,235 at 10.02
7.6%
3 Feb 2023
Ticho Barry Chief Medical Officer
Sold, plan not stated
$37.75K 3,763 at 10.03
3.0%
2 Feb 2023
Ticho Barry Chief Medical Officer
Sold, plan not stated
$2.67K 267 at 10.00
0.2%
1 Feb 2023
Ticho Barry Chief Medical Officer
Sold, plan not stated
$57.14K 5,705 at 10.02
4.4%
31 Jan 2023
Ticho Barry Chief Medical Officer
Sold, plan not stated
$2.00K 200 at 10.00
0.2%
3 Jan 2022
Nash Huw M. COO & CBO
Sold, plan not stated 3×
$87.67K 3,800 at 23.07
100%
Sold half or more
1 Dec 2021
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$139.33K 5,700 at 24.44
100%
Sold half or more
3 Nov 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$47.50K 1,900 at 25.00
100%
Sold half or more
1 Nov 2021
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$89.46K 3,800 at 23.54
100%
Sold half or more
1 Oct 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$141.51K 5,700 at 24.83
100%
Sold half or more
1 Sep 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$148.22K 5,700 at 26.00
100%
Sold half or more
2 Aug 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$164.55K 5,700 at 28.87
100%
Sold half or more
13 Jul 2021
Ticho Barry Chief Medical Officer
Sold, plan not stated 2×
$1.41M 43,166 at 32.75
24.8%
1 Jul 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$189.99K 5,700 at 33.33
100%
Sold half or more
1 Jun 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$22.67K 575 at 39.43
100%
Sold half or more
2 Mar 2021
Liau Gene EVP Research & Preclinical Dev
Sold, plan not stated 2×
$327.55K 5,195 at 63.05
19.6%
1 Mar 2021
LEVIN ARTHUR A Director
Sold, plan not stated 2×
$759.84K 12,500 at 60.79
100%
Sold half or more
23 Feb 2021
Sold, plan not stated
$292.99K 5,000 at 58.60
89.3%
Sold half or more
22 Feb 2021
Sold, plan not stated 3×
$1.47M 25,000 at 58.92
97.6%
Sold half or more
19 Feb 2021
TZIANABOS ARTHUR Director
Sold, plan not stated
$606.65K 10,000 at 60.67
100%
Sold half or more
6 Jan 2021
Nash Huw M. COO & CBO
Sold, plan not stated
$1.83K 32 at 57.14
100%
Sold half or more
4 Jan 2021
Nash Huw M. COO & CBO
Sold, plan not stated 4×
$336.16K 5,700 at 58.97
99.4%
Sold half or more
28 Dec 2020
Liau Gene EVP Research & Preclinical Dev
Sold, plan not stated
$8.75K 149 at 58.73
0.7%
21 Dec 2020
Ticho Barry Chief Medical Officer
Sold, plan not stated 3×
$78.65K 1,365 at 57.62
0.8%
18 Dec 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$480.90K 8,015 at 60.00
100%
Sold half or more
18 Dec 2020
Sold, plan not stated
$311.64K 5,194 at 60.00
100%
Sold half or more
17 Dec 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$2.52M 41,985 at 60.00
100%
Sold half or more
17 Dec 2020
Sold, plan not stated
$1.19M 19,806 at 60.00
79.2%
Sold half or more
1 Dec 2020
Nash Huw M. COO & CBO
Sold, plan not stated 4×
$284.08K 5,700 at 49.84
100%
Sold half or more
27 Nov 2020
Sold, plan not stated
$607.60K 12,152 at 50.00
32.7%
25 Nov 2020
Sold, plan not stated
$642.40K 12,848 at 50.00
25.7%
24 Nov 2020
Harrison Seth Loring Director · indirect
Bought
$14.63M 375,000 at 39.00
2.2%
First buy on file
24 Nov 2020
Bought
$14.63M 375,000 at 39.00
2.2%
First buy on file
23 Nov 2020
TZIANABOS ARTHUR Director
Sold, plan not stated 4×
$920.57K 20,000 at 46.03
100%
Sold half or more
10 Nov 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$2.25M 50,000 at 45.00
100%
Sold half or more
4 Nov 2020
Sold, plan not stated 3×
$1.36M 33,268 at 40.80
98.2%
Sold half or more
3 Nov 2020
Sold, plan not stated
$69.00K 1,732 at 39.84
74.2%
Sold half or more
2 Nov 2020
Sold, plan not stated 3×
$1.30M 35,000 at 37.25
98.3%
Sold half or more
2 Nov 2020
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$212.11K 5,700 at 37.21
100%
Sold half or more
19 Oct 2020
Liau Gene EVP Research & Preclinical Dev
Sold, plan not stated 2×
$1.21M 32,000 at 37.82
70.3%
Sold half or more
16 Oct 2020
Liau Gene EVP Research & Preclinical Dev
Sold, plan not stated
$234.04K 5,851 at 40.00
30.2%
13 Oct 2020
Liau Gene EVP Research & Preclinical Dev
Sold, plan not stated
$65.96K 1,649 at 40.00
10.9%
1 Oct 2020
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$196.90K 5,700 at 34.54
100%
Sold half or more
9 Sep 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$516.03K 17,201 at 30.00
100%
Sold half or more
8 Sep 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$921.54K 30,718 at 30.00
100%
Sold half or more
1 Sep 2020
Nash Huw M. COO & CBO
Sold, plan not stated 2×
$158.11K 5,700 at 27.74
100%
Sold half or more
28 Aug 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$62.43K 2,081 at 30.00
100%
Sold half or more
3 Aug 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$140.94K 5,700 at 24.73
100%
Sold half or more
16 Jul 2020
Nash Huw M. COO & CBO
Sold, plan not stated
$47.61K 1,900 at 25.06
100%
Sold half or more
7 Jul 2020
Walker Robin A. Chief Legal Officer, CCO & Sec
Sold, plan not stated
$21.17K 941 at 22.50
100%
Sold half or more
Showing 1–50 of 66. Page 1 of 2 Older →